Overview



We are a worldwide leader in the design, development, manufacture and support of
process control tools that perform macro-defect inspection and metrology,
lithography systems, and process control analytical software used by
semiconductor and advanced packaging device manufacturers. We deliver
comprehensive solutions throughout the semiconductor fabrication process with
our families of proprietary products that provide critical yield-enhancing
information, enabling microelectronic device manufacturers to drive down costs
and time to market of their devices. We provide process and yield management
solutions used in both wafer processing facilities, often referred to as
"front-end" and device packaging and test facilities, or "back-end"
manufacturing, through a portfolio of standalone systems for macro-defect
inspection, lithography, probe card test and analysis, and transparent and
opaque thin film measurements. All of our systems feature sophisticated software
and production-worthy automation. In addition, our advanced process control
software portfolio includes powerful solutions for standalone tools, groups of
tools, or factory-wide suites to enhance productivity and achieve significant
cost savings. Our systems are backed by worldwide customer service and
applications support.

Our business is affected by the annual spending patterns of our customers on
semiconductor capital equipment. The amount that our customers devote to capital
equipment spending depends on a number of factors, including general worldwide
economic conditions as well as other economic drivers such as personal
computers, mobile devices, data centers, artificial intelligence and automotive
sales. Current forecasts by industry analysts for the semiconductor device
manufacturing industry project capital equipment spending to increase
approximately 5% to 8% for 2020 as compared to 2019. Our revenue and
profitability tend to follow the trends of certain segments within the
semiconductor market.

Historically, a significant portion of our revenue in each quarter and year has
been derived from sales to relatively few customers, and we expect this trend to
continue. For the years ended December 31, 2019, 2018 and 2017, aggregate sales
to customers that individually represented at least five percent of our revenue
accounted for 42.7%, 18.3%, and 27.2% of our revenue, respectively.

Merger



On June 23, 2019, Rudolph and Nanometrics, a provider of advanced process
control metrology and software analytics, entered into the Merger Agreement to
combine in an all-stock merger of equals transaction. The Merger was completed
on October 25, 2019. As a result of the Merger, Rudolph became a direct
wholly-owned subsidiary of Nanometrics, which was renamed "Onto Innovation Inc."
upon the consummation of the Merger. Shares of common stock of Rudolph (NYSE:
RTEC) ceased trading on the New York Stock Exchange as of market close on
October 25, 2019. Onto Innovation (NYSE: ONTO) shares began trading on the NYSE
on October 28, 2019. At the effective time of the Merger, each issued and
outstanding share of Rudolph Common Stock was converted into the right to
receive 0.8042 shares of Onto Innovation Common Stock (NYSE: ONTO). Immediately
following the effective time of the Merger, each of Nanometrics' and Rudolph's
stockholders owned approximately 50% of the combined company, Onto Innovation.
Pursuant to the Merger Agreement, Onto Innovation accounts for the Merger as a
reverse acquisition using the acquisition method of accounting in accordance
with generally accepted accounting principles, with Rudolph being treated as the
acquiring entity for accounting purposes. As such, the results of operations
data below comprise the operating results of Rudolph and its consolidated
subsidiaries for periods through October 25, 2019 and Onto Innovation and its
consolidated subsidiaries for periods on or after October 26, 2019. See Note 3
to the Consolidated Financial Statements set forth elsewhere in this Annual
Report on Form 10-K for additional information regarding the Merger.



                                       29

--------------------------------------------------------------------------------


  Table of Contents



Results of Operations

The following table sets forth, for the periods indicated, our results of operations as percentages of our revenue. Our results of operations are reported as one business segment.





                                                         Year Ended December 31,
                                                   2019            2018           2017
Revenue                                              100.0 %         100.0 %        100.0 %
Cost of revenue                                       55.9 %          45.8 %         47.2 %
Gross profit                                          44.1 %          54.2 %         52.8 %
Operating expenses:
Research and development                              15.8 %          14.6 %         14.8 %
Sales and marketing                                    9.2 %           8.0 %          8.1 %
General and administrative                            17.4 %          12.3 %         10.9 %
Amortization                                           3.4 %           0.6 %          0.8 %
Patent litigation income                                 - %             - %         (5.1 )%
Total operating expenses                              45.8 %          35.5 %         29.5 %
Operating income (loss)                               (1.7 )%         18.7 %         23.3 %
Interest income, net                                   1.2 %           0.8 %          0.4 %
Other income (expense), net                            0.3 %             - %         (0.2 )%
Income (loss) before provision (benefit) for
income taxes                                          (0.2 )%         19.5 %         23.5 %
Provision (benefit) for income taxes                  (0.8 )%          3.0 %         10.6 %
Net income                                             0.6 %          16.5 %         12.9 %

Results of Operations for 2019, 2018 and 2017



Revenue. Our revenue is derived from the sale of our systems and software, spare
parts, and services. Our revenue was $305.9 million, $273.8 million and $255.1
million for the years ended December 31, 2019, 2018 and 2017, respectively. This
represents an increase of 11.7% from 2018 to 2019 and an increase of 7.3% from
2017 to 2018. The increase in revenue from 2018 to 2019 was primarily due to the
inclusion of revenue from legacy Nanometrics business for the period from
October 25, 2019, the effective date of the Merger, through December 31,
2019. This year-over-year increase in revenue was partially offset by overall
spending declines in the semiconductor capital equipment industries. The
increase in revenue from 2017 to 2018 was primarily due to an increase in
capital spending by front-end memory manufacturers.

The following table lists, for the periods indicated, the different sources of our revenue in dollars (thousands) and as percentages of our total revenue:



                                             Year Ended December 31,
                              2019                    2018                    2017
Systems and software   $ 255,723        84 %   $ 234,241        86 %   $ 216,884        85 %
Parts                     34,892        11 %      28,658        10 %      27,143        11 %
Services                  15,281         5 %      10,885         4 %      11,071         4 %
Total revenue          $ 305,896       100 %   $ 273,784       100 %   $ 255,098       100 %


Total systems and software revenue increased $21.5 million for the year ended
December 31, 2019 as compared to the year ended December 31, 2018 primarily due
to the inclusion of revenue from legacy Nanometrics for the period from the
effective date of the Merger. The year-over-year change in systems revenue was
driven by an increase of $29.9 million in process control systems revenue due to
inclusion of $56.0 million of revenue from legacy Nanometrics for the period
from the effective date of the Merger. This increase was partially offset by
decreased demand for our products in both advanced packaging and front-end
systems. Software licensing, support and maintenance revenue decreased $4.0
million, primarily due to a decrease in revenue from our process control and
yield management software. The year-over-year increase in parts and services
revenue in absolute dollars from 2018 to 2019 was primarily due to the inclusion
of $10.3 million of parts and service revenue from legacy Nanometrics for the
period from the effective date of the Merger. Parts and services revenue is
generated from part sales, maintenance service contracts, system upgrades, as
well as time and material billable service calls.

Total systems and software revenue increased for the year ended December 31,
2018 as compared to the year ended December 31, 2017 due to increased demand for
our products in front-end process control systems. The year-over-year increases
in process control systems revenue totaled $12.9 million, primarily due to
higher metrology system sales in the 2018 period. Lithography system revenue
increased $0.7 million, primarily due to the shipment of a JetStep G system
offset by lower shipments of our JetStep W systems in 2018. Licensing revenue
from software increased $3.7 million primarily due



                                       30

--------------------------------------------------------------------------------

Table of Contents





to an increase in revenue from our process control and yield management
software. The year-over-year increase in parts and services revenue in absolute
dollars from 2017 to 2018 was primarily due to increased spending by our
customers on repairs of existing systems. Parts and services revenue is
generated from part sales, maintenance service contracts, system upgrades, as
well as time and material billable service calls.

Gross Profit. Our gross profit has been and will continue to be affected by a
variety of factors, including inventory step-up from purchase accounting,
manufacturing efficiencies, provision for excess and obsolete inventory, pricing
by competitors or suppliers, new product introductions, production volume,
customization and reconfiguration of systems, international and domestic sales
mix, system and software product mix, and parts and services margins. Our gross
profit was $135.0 million, $148.3 million and $134.6 million for the years ended
December 31, 2019, 2018 and 2017, respectively. Our gross profit represented
44.1%, 54.2% and 52.8% for the years ended December 31, 2019, 2018 and 2017,
respectively. The decrease in gross profit as a percentage of revenue from 2018
to 2019 was primarily due to charges to cost of goods sold including a $15.4
million charge for the sale of inventory written-up to fair value upon the
Merger and $7.8 million in additional charges related to excess and obsolete
inventory. The increase in gross profit as a percentage of revenue from 2017 to
2018 was primarily due to a change in our systems and software product sales mix
and the sale of a lithography system that had previously been partially written
down.

Operating Expenses

Our operating expenses consist of:

• Research and Development. The process control defect inspection and

metrology, advanced packaging lithography, and data analysis systems and

software market is characterized by continuous technological development


         and product innovations. We believe that the rapid and ongoing
         development of new products and enhancements of existing products,
         including the transition to copper and low-k dielectrics, wafer level
         packaging, the continuous shrinkage in critical dimensions, and the

evolution of ultra-thin gate process control is critical to our success.

Accordingly, we devote a significant portion of our technical, management

and financial resources to research and development programs. Research

and development expenditures consist primarily of salaries and related

expenses of employees engaged in research, design and development

activities. They also include consulting fees, the cost of related

supplies and legal costs to defend our patents. Our research and

development expenses were $48.4 million, $40.0 million and $37.7 million

in 2019, 2018 and 2017, respectively. The year-over-year dollar increase

from 2018 to 2019 was primarily due to increased compensation resulting

from the inclusion of $7.4 million in research and development expense of

legacy Nanometrics resulting from the Merger. The year-over-year dollar

increase from 2017 to 2018 was primarily due to increased compensation

and development initiatives. These costs were partially offset by

decreased litigation expenses. We continue to maintain our commitment to


         investing in new product development and enhancement to existing
         products.

• Sales and Marketing. Sales and marketing expenses are primarily comprised

of salaries and related costs for sales and marketing personnel, as well

as commissions and other non-personnel related expenses. Our sales and

marketing expenses were $28.3 million, $22.0 million and $20.8 million in

2019, 2018 and 2017, respectively. The year-over-year dollar increase

from 2018 to 2019 was primarily due to the inclusion of $6.9 million in

sales and marketing expenses of legacy Nanometrics resulting from the

Merger. The year-over-year increase from 2017 to 2018 was primarily due

to compensation costs resulting from headcount and salary increases and


         an increase in sales commissions


     •   General and Administrative. General and administrative expenses are
         primarily comprised of salaries and related costs for general
         administrative personnel, as well as other non-personnel related

expenses. Our general and administrative expenses were $53.0 million,

$33.7 million and $27.9 million in 2019, 2018 and 2017, respectively. The


         year-over-year dollar increase from 2018 to 2019 was primarily due to the
         inclusion of $4.4 million in general and administrative expenses of

legacy Nanometrics resulting from the Merger. In addition, we incurred

$14.8 million in merger expenses for bankers fees, legal, accounting, and


         change in control compensation expenses. The year-over-year dollar
         increase from 2017 to 2018 was primarily due to compensation costs
         resulting from headcount and salary increases.


     •   Amortization of Identifiable Intangible Assets.  Amortization of

identifiable intangible assets was $10.4 million, $1.5 million and $1.9

million in 2019, 2018 and 2017, respectively. The year-over-year increase

in amortization expense from 2018 to 2019 was due additional amortization

recorded associated with additional purchased intangible assets recorded

as a result of the Merger. The year-over-year decreases in amortization

expense from 2017 to 2018 were due to certain intangible assets becoming


         fully amortized during these periods.




                                       31

--------------------------------------------------------------------------------


  Table of Contents


• Patent Litigation Income. During the twelve months ended December 31,

2019 and 2018, there was no patent litigation income. During the twelve

months ended December 31, 2017, we recorded income and received cash of

$13.0 million from a comprehensive settlement regarding a patent

infringement litigation with Camtek.




Interest income (expense), net. In 2019, 2018 and 2017, net interest income was
$3.7 million, $2.2 million and $1.0 million, respectively. The increase in net
interest income from 2018 to 2019 was due to interest earned on our marketable
securities and additional interest income on a higher marketable securities
balance following the Merger with Nanometrics. The increase in net interest
income from 2017 to 2018 was due to higher interest earned on our marketable
securities.

Income taxes. The following table provides details of income tax (dollars in
millions):



                                           Year Ended December 31,
                                         2019          2018       2017
Income before income taxes             $    (0.6 )    $ 53.3     $ 59.8

Provision (benefit) for income taxes $ (2.5 ) $ 8.3 $ 26.9 Effective tax rate

                         419.9 %      15.5 %     45.0 %




The income tax provision differs from the federal statutory income tax rate of
21% for 2019 primarily due to a benefit related to the Foreign Derived
Intangible Income Deduction ("FDII") of $2.3 million and tax benefits for
research and development credits of $2.1 million, partially offset by
non-deductible transaction costs of $1.1 million and Section 162(m) limitation
on the deductibility of executive compensation of $0.8 million.

The income tax provision differs from the federal statutory income tax rate of
21% for 2018 primarily due to Foreign Derived Intangible Income Deduction
("FDII") from Public law No. 115-97, known as the Tax Cuts and Jobs Act (the
"Tax Act") of $2.2 million, tax benefits for research and development credits of
$2.3 million, offset by a Section 162(m) limitation on the deductibility of
executive compensation of $0.5 million and additional Accounting Standards
Codification ("ASC") 740-10 tax reserves of $0.6 million.

The income tax provision differs from the federal statutory income tax rate of
21% for 2017 primarily due to new regulations resulting from the Tax Act of $9.5
million, offset by tax benefits for research and development credits of $1.6
million, section 199 manufacturing deduction of $1.6 million and excess tax
benefits on vesting of restricted stock of $1.6 million.

The Tax Act, which was enacted and signed into law on December 22, 2017, reduced
the U.S. federal corporate tax rate from 35% to 21%, effective January 1, 2018.
Also, on December 22, 2017, the SEC issued Staff Accounting Bulletin No. 118
("SAB 118"), which provides guidance on accounting for tax effects of the Tax
Act. SAB 118 provides a measurement period of up to one year from the enactment
date to complete the accounting. Any adjustments during this measurement period
will be included in net earnings from continuing operations as an adjustment to
income tax expense in the reporting period when such adjustments are determined.
Based on the information available and current interpretation of the rules, we
estimated the impact of the reduction in the corporate tax rate and
remeasurement of certain deferred tax assets and liabilities. The provisional
amount recorded in the fourth quarter of 2017 related to the remeasurement of
our deferred tax balance resulted in additional income tax expense of $8.0
million. During the fourth quarter of 2018, we completed the accounting for such
revaluation and recorded an additional $0.8 million in tax expense. The prior
year provisional impact and current year finalization of the Tax Act summarized
below, which is included as a component of the provision from income taxes is
further described in Note 12 in the accompanying Notes to the Consolidated
Financial Statements included in this Annual Report on Form 10-K (dollars in
millions).

                                                            Year Ended December 31,
                                                         2019                    2018
Re-measurement of U.S. deferred tax assets and
liabilities                                         $             -         $             -
Transition tax on non-U.S. subsidiaries' earnings                 -                     0.1
Foreign tax credits applied against transition
tax                                                               -                       -
Valuation allowance for unused foreign tax
credits                                                         1.0                     0.7
   Total impact of the Tax Act on the provision
for income taxes                                    $           1.0         $           0.8


Our future effective income tax rate depends on various factors, such as future
impacts of the Tax Act, possible further tax legislation, the geographic
composition of our pre-tax income, the amount of our pre-tax income as business
activities fluctuate, non-deductible expenses incurred in connection with
acquisitions and research and development credits as a percentage of aggregate
pre-tax income.



                                       32

--------------------------------------------------------------------------------

Table of Contents

Liquidity and Capital Resources

At December 31, 2019, we had $320.2 million of cash, cash equivalents and marketable securities and $555.9 million in working capital. At December 31, 2018, our cash, cash equivalents and marketable securities totaled $175.1 million, while working capital amounted to $305.9 million.



Net cash and cash equivalents provided by operating activities for the years
ended December 31, 2019, 2018 and 2017 totaled $18.1 million, $35.1 million and
$64.2 million, respectively. During the year ended December 31, 2019, cash
provided by operating activities was primarily due to net income, adjusted to
exclude the effect of non-cash charges, of $53.5 million, a decrease in income
taxes of $7.6 million, which were partially offset by a decrease in accounts
payable of $12.1 million, a decrease in accrued and other liabilities of $6.7
million, an increase in inventories of $9.3 million, an increase in accounts
receivable of $9.7 million and an increase in prepaid expenses and other assets
of $5.1 million.

During the year ended December 31, 2018, cash provided by operating activities
was primarily due to net income, adjusted to exclude the effect of non-cash
charges, of $64.3 million, an increase in accounts payable of $3.5 million, a
decrease in income taxes of $1.1 million, a decrease in account receivable of
$0.7 million and an increase in accrued and other liabilities of $0.2 million,
which were partially offset by an increase in inventories of $31.5 million, and
an increase in prepaid expenses and other assets of $3.1 million. The increase
in inventories of $31.5 million was primarily due to increased sales projections
of our latest products and new product initiatives.

During the year ended December 31, 2017, cash provided by operating activities
was primarily due to net income, adjusted to exclude the effect of non-cash
charges, of $65.9 million, an increase in accrued and other liabilities of $5.2
million, an increase in accounts payable of $3.2 million and a decrease in
account receivable of $0.4 million, which were partially offset by an increase
in income taxes of $4.7 million, an increase in inventory of $4.2 million, and
an increase in prepaid expenses and other assets of $1.7 million.

Net cash and cash equivalents provided by investing activities for the years
ended December 31, 2019 and 2018 was $4.1 million and $33.8 million,
respectively. Net cash and cash equivalents used in investing activities for the
year ended December 31, 2017 totaled $32.5 million. During the year ended
December 31, 2019, net cash provided by investing activities included proceeds
from maturities and sales of marketable securities of $94.5 million and cash
acquired in the Merger of $43.9 million, which were partially offset by
purchases of marketable securities of $127.5 million and purchases of property,
plant and equipment of $6.8 million. During the year ended December 31, 2018,
net cash provided by investing activities included proceeds from sales of
marketable securities of $186.3 million, which was partially offset by purchases
of marketable securities of $140.0 million, purchases of property, plant and
equipment of $7.5 million and cash advanced on a convertible note receivable of
$5.0 million. During the year ended December 31, 2017, net cash used in
investing activities included purchases of marketable securities of $164.7
million, purchases of property, plant and equipment of $10.2 million, and
purchase of intangible assets of $1.0 million, which were partially offset by
proceeds from sales of marketable securities of $143.3 million.

Net cash used in financing activities was $4.2 million, $23.9 million and $2.6
million in 2019, 2018 and 2017, respectively. During the year ended December 31,
2019, financing activities used cash to pay taxes related to shares withheld for
share based compensation plans of $2.5 million, pay contingent consideration for
acquired business of $1.8 million, and purchase shares of our common stock under
share repurchase authorizations of $0.7 million. These uses of cash were
partially offset by proceeds from sales of shares through employee stock plans
of $0.8 million. During the year ended December 31, 2018, financing activities
used cash to purchase shares of our common stock under share repurchase
authorizations of $21.1 million, pay taxes related to shares withheld for share
based compensation plans of $1.9 million and pay contingent consideration for
acquired business of $1.5 million. These uses of cash were partially offset by
proceeds from sales of shares through employee stock plans of $0.6
million. During the year ended December 31, 2017, financing activities included
the redemption of stock warrants of $1.0 million, tax payments related to shares
withheld for share-based compensation plans of $1.4 million and payment of
contingent consideration for acquired businesses of $0.8 million, which were
partially offset by proceeds from sales of shares through employee stock plans
of $0.6 million.

From time to time, we evaluate whether to acquire new or complementary
businesses, products and/or technologies. We may fund all of or a portion of the
price of these investments or acquisitions in cash, stock, or a combination of
cash and stock.

On May 31, 2018, we entered into a convertible loan agreement with Simax
Precision Technologies Limited ("the borrower"), which allowed them to borrow up
to $15.0 million in multiple promissory notes with an interest rate of 4.25% per
annum payable on a semi-annual basis. We expected to be a supplier of
lithography modules to Simax, which is used in the manufacture, sale and service
of lithography systems. At December 31, 2019, we had $5.0 million in outstanding
convertible notes receivable with the borrower.



                                       33

--------------------------------------------------------------------------------

Table of Contents





During the fourth quarter of 2019, we began negotiations with the borrower to
end our relationship as it pertains to this agreement. We determined that it is
unlikely that a portion of the convertible note receivable will be collectable,
and a reserve in the amount of $2.0 million was recorded during the period ended
December 31, 2019. In addition, we ceased recognizing interest income on these
convertible notes receivable as of September 30, 2019. See Note 8 in the
accompanying Notes to the Consolidated Financial Statements included in this
Annual Report on Form 10-K for further information.

Following the Merger, we assumed the share repurchase authorization approved on
March 14, 2019, by the former Nanometrics Board of Directors. This share
repurchase authorization allows us to purchase up to $80.0 million worth of
shares of our common stock. Under the terms of this share repurchase
authorization, shares may be repurchased through open market or privately
negotiated transactions. No shares have been repurchased under this repurchase
authorization.

For further information regarding our share repurchases, see Note 18 in the accompanying Notes to the Consolidated Financial Statements included in this Annual Report on Form 10-K.



We have a credit agreement with a bank that provides for a line of credit that
is secured by the marketable securities we have with the bank. We are permitted
to borrow up to 70% of the value of eligible securities held at the time the
line of credit is accessed. As of December 31, 2019, the available line of
credit was approximately $91.3 million with an available interest rate of
3.3%. The credit agreement is available to us until such time that either party
terminates the arrangement at its discretion.  To date, we have not utilized the
line of credit.

Our future capital requirements will depend on many factors, including the
timing and amount of our revenue and our investment decisions, which will affect
our ability to generate additional cash. We expect that our existing cash, cash
equivalents, marketable securities and availability under our line of credit
will be sufficient to meet our anticipated cash requirements for working
capital, capital expenditures and other cash needs for the next 12 months
following the filing of this Form 10-K. Thereafter, if cash generated from
operations and financing activities is insufficient to satisfy our working
capital requirements, we may seek additional funding through bank borrowings,
sales of securities or other means. There can be no assurance that we will be
able to raise any such capital on terms acceptable to us or at all.

Contractual Obligations



The following table summarizes our significant contractual obligations at
December 31, 2019, and the effect such obligations are expected to have on our
liquidity and cash flows in future periods. This table excludes the liability
for unrecognized tax benefits that totaled approximately $10.6 million at
December 31, 2019. We are currently unable to provide a reasonably reliable
estimate of the amount or periods when cash settlement of this liability may
occur (dollars in thousands).



                                                             Payments due by period
                                                     Less than 1        1-3          3-5         More than
                                        Total           year           years        years         5 years
Operating lease obligations           $  29,152     $       5,901     $ 12,116     $  5,856     $     5,279
Open and committed purchase orders       97,877            93,705        4,172            -               -
Total                                 $ 127,029     $      99,606     $ 16,288     $  5,856     $     5,279

Off-Balance Sheet Arrangements



The Company does not have any off-balance sheet arrangements that have or are
reasonably likely to have a material effect on our financial condition, results
of operations or liquidity and capital resources.

Critical Accounting Policies



Management's discussion and analysis of our financial condition and results of
operations are based upon our Consolidated Financial Statements included in this
Annual Report on Form 10-K, which have been prepared in accordance with
accounting principles generally accepted in the United States. We review the
accounting policies we use in reporting our financial results on a regular
basis. The preparation of these financial statements requires us to make
estimates and judgments that affect the reported amounts of assets, liabilities,
revenue and expenses and related disclosure of contingent assets and
liabilities. On an ongoing basis, we evaluate our estimates, including those
related to revenue recognition, accounts receivable, inventories, business
acquisitions, intangible assets, share-based payments, income taxes and warranty
obligations. We base our estimates on historical experience and on various other
assumptions that are believed to be reasonable under the circumstances, the
results of which form the basis for making judgments about the carrying value of
assets and liabilities that are not readily apparent from other sources. Results
may differ from these estimates due to actual outcomes being different from
those on which we based our assumptions. These estimates and judgments are
regularly



                                       34

--------------------------------------------------------------------------------

Table of Contents





reviewed by management on an ongoing basis at the end of each quarter prior to
the public release of our financial results. We believe the following critical
accounting policies affect our more significant judgments and estimates used in
the preparation of our Consolidated Financial Statements.

Revenue Recognition. Effective January 1, 2018, we adopted the requirements of
Accounting Standards Update ("ASU") No. 2014-09, "Revenue from Contracts with
Customers (Topic 606)."

Revenue is recognized when control of the promised goods or services are
transferred to our customers in an amount that reflects the consideration we
expect to be entitled to receive in exchange for those goods or services. We
account for a contract when it has approval and commitment from both parties,
the rights of the parties and payment terms are identified, the contract has
commercial substance and collectability of consideration is probable.

We account for shipping and handling activities as the fulfillment of a promise
to transfer goods to the customer and therefore record these activities under
the caption "Cost of revenue." Sales tax and any other taxes collected
concurrent with revenue producing activities are excluded from revenue.
Incidental items that are immaterial in the context of the contract are
recognized as expense.

Contracts with customers may include multiple performance obligations. For such
arrangements, we allocate revenue to each performance obligation based on its
relative standalone selling price. We generally determine standalone selling
prices based on the prices charged to customers or the expected cost-plus
margin.

Revenue from systems is recognized when we transfer control of the product to
our customer. To indicate transfer of control, we must have a present right to
payment, legal title must have passed to the customer and the customer must have
the significant risks and rewards of ownership. We generally transfer control
for system sales when the customer or the customer's agent picks up the system
at our facility. Payment for the majority of our systems have 80-90% of the
invoice amount due within 30 days and the remaining amount due upon completion
of installation, recalibration and qualification by the customer. We provide an
assurance warranty on our systems for a period of twelve to fourteen months
against defects in material and workmanship. We provide for the estimated cost
of product warranties at the time revenue is recognized.

Depending on the terms of the systems arrangement, we may also defer the
recognition of a portion of the consideration expected to be received because we
have to satisfy a future obligation (e.g., installation, training and extended
warranties). We use an observable price to determine the standalone selling
price for separate performance obligations or a cost-plus margin approach when
one is not available.

Revenue from software licenses is recognized upfront at the point in time when
the software is made available to the customer. Software licenses provide the
customer with limited rights to use the software. Revenue from licensing support
and maintenance is recognized as the support and maintenance are provided, which
is over the contract period. Payment for software licensing, support and
maintenance is generally due in 30 days.

Revenue from parts is recognized when we transfer control of the product, which
typically occurs when we ship the product from our facilities to the customer.
Payment for parts is generally due in 30 days.

Revenue from services primarily consists of service contracts, which provide
additional maintenance coverage beyond our assurance warranty on our products,
service labor, consulting and training. Revenue from service contracts is
recognized ratably over the term of the service contract. Revenue from service
labor, consulting and training is recognized as services are performed. Payment
for services is generally due in 30 days.

We record contract liabilities when the customer has been billed in advance of
completing our performance obligations. These amounts are recorded as deferred
revenue in the Consolidated Balance Sheets.

Business combinations. We account for business combinations under the
acquisition method of accounting, which requires us to recognize separately from
goodwill the assets acquired, and the liabilities assumed at their acquisition
date fair values. While we use our best estimates and assumptions to accurately
value assets acquired and liabilities assumed at the acquisition date as well as
contingent consideration, where applicable, our estimates are inherently
uncertain and subject to refinement. As a result, during the measurement period,
which may be up to one year from the acquisition date, we record adjustments to
the assets acquired and liabilities assumed with the corresponding offset to
goodwill. Upon the conclusion of the measurement period or final determination
of the values of assets acquired or liabilities assumed, whichever comes first,
any subsequent adjustments are recognized in our consolidated statements of
operations. Accounting for business combinations requires our management to make
significant estimates and assumptions, especially at the acquisition date
including our estimates for intangible assets, contractual obligations assumed,
restructuring liabilities, pre-acquisition contingencies, and contingent
consideration, where applicable. Although we believe the assumptions and
estimates we have made in the past have been reasonable and appropriate, they
are based, in part, on historical experience and information obtained from the
management of the acquired companies and are inherently uncertain. Estimates in
valuing certain acquired



                                       35

--------------------------------------------------------------------------------

Table of Contents





intangible assets under the income approach include growth in future expected
cash flows from product sales, acquired technologies, technology obsolescence
rates, estimated cash flows from the projects when completed and discount rates.
Unanticipated events and circumstances may occur that may affect the accuracy or
validity of such assumptions, estimates or actual results.

Excess and Obsolete Inventory. We maintain reserves for our excess and obsolete
inventory equal to the difference between the cost of inventory and the
estimated market value based upon assumptions about future product lifecycles,
product demand and market conditions. If actual product lifecycles, product
demand and market conditions are less favorable than those originally projected
by management, additional inventory write-downs may be required.

Long-Lived Assets and Acquired Intangible Assets. We periodically review
long-lived assets, other than goodwill, for impairment whenever changes in
events or circumstances indicate that the carrying amount of an asset may not be
recoverable. Assumptions and estimates used in the determination of impairment
losses, such as future cash flows and disposition costs, may affect the carrying
value of long-lived assets and the impairment of such long-lived assets, if any,
could have a material effect on our consolidated financial statements. During
the year ended December 31, 2019, we recognized a $0.5 million impairment loss
on long-lived assets. No such indicators were noted in 2018 or 2017.

Accounting for Income Taxes. As part of the process of preparing our
consolidated financial statements, we are required to estimate our actual
current tax exposure together with our temporary differences resulting from
differing treatment of items for tax and accounting purposes. These temporary
differences result in deferred tax assets and liabilities, which are included
within our consolidated balance sheet. We must then assess the likelihood that
our deferred tax assets will be recovered from future taxable income and to the
extent we believe that recovery is not likely, we must establish a valuation
allowance. Management judgment is required in determining our provision for
income taxes and any valuation allowance recorded against our deferred tax
assets. The need for a valuation allowance is based on our estimates of taxable
income by jurisdiction in which we operate and the period over which our
deferred taxes will be recoverable. In the event that actual results differ from
these estimates or we adjust these estimates in future periods, we may need to
adjust the valuation allowance, which could materially impact our financial
position and results of operations. At December 31, 2019 and 2018, we had
recorded valuation allowances of $14.2 million and $3.2 million on certain of
our deferred tax assets to reflect the deferred tax assets at the net amount
that is more likely than not to be realized. We evaluated the realizability of
the deferred tax assets based on positive earnings as well as the projected
earnings in future years and believe it is more likely than not that the
substantial majority of our deferred tax asset will be realized in the future
years. We will continue to monitor the realizability of the deferred tax assets
and evaluate the valuation allowance.

We recognize liabilities for uncertain tax positions based on a two-step
process. The first step requires us to determine if the weight of available
evidence indicates that the tax position has met the threshold for recognition;
therefore, we must evaluate whether it is more likely than not that the position
will be sustained on audit, including resolution of any related appeals or
litigation processes. The second step requires us to measure the tax benefit of
the tax position taken, or expected to be taken, in an income tax return as the
largest amount that is more than 50% likely of being realized when effectively
settled. This measurement step is inherently difficult and requires subjective
estimations of such amounts to determine the probability of various possible
outcomes. We reevaluate the uncertain tax positions each quarter based on
factors including, but not limited to, changes in facts or circumstances,
changes in tax law, effectively settled issues, and new audit activity. Such a
change in recognition or measurement could result in the recognition of a tax
benefit or an additional charge to the tax provision in the period.

Although we believe the measurement of our liabilities for uncertain tax
positions is reasonable, no assurance can be given that the final outcome of
these matters will not be different than what is reflected in the historical
income tax provisions and accruals. If additional taxes are assessed as a result
of an audit or litigation, it could have a material effect on our income tax
provision and net income in the period or periods for which that determination
is made.

Impact of Recent Accounting Pronouncements

Recently Adopted



Effective January 1, 2019, we adopted ASU No. 2018-07, "Compensation - Stock
Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment
Accounting." This ASU expands the scope of Topic 718 to include share-based
payment transactions for acquiring goods and services from nonemployees. An
entity should apply the requirements of Topic 718 to nonemployee awards except
for specific guidance on inputs to an option pricing model and the attribution
of cost. The ASU is effective for the fiscal years beginning after December 15,
2018, including interim periods within that fiscal year. The adoption of ASU No.
2018-07 did not have a material impact on our consolidated financial position,
results of operations, and cash flows.



                                       36

--------------------------------------------------------------------------------

Table of Contents





Effective January 1, 2019, we adopted ASU No. 2018-02, "Income Statement -
Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax
Effects from Accumulated Other Comprehensive Income." The new guidance allows
companies to reclassify stranded tax effects resulting from the Tax Act from
accumulated other comprehensive income to retained earnings. The guidance also
requires certain new disclosures regardless of a company's election. The
standard is effective for annual periods beginning after December 15, 2018 and
for interim periods within those annual periods, with earlier adoption
permitted. The adoption of ASU No. 2018-02 did not have a material impact on our
consolidated financial position, results of operations, and cash flows.

In January 2017, the Financial Accounting Standards Board ("FASB") issued ASU
No. 2017-04, "Intangibles - Goodwill and Other (Topic 350): Simplifying the Test
for Goodwill Impairment." This ASU eliminates Step 2 from the goodwill
impairment test.  Accordingly, if the carrying amount of a reporting unit
exceeds its fair value, an impairment loss will be recognized in an amount equal
to the excess, limited to the total amount of goodwill allocated to the
reporting unit. The ASU is effective for the fiscal years beginning after
December 15, 2019 and for interim periods within those fiscal years, with
earlier adoption permitted. The adoption of ASU No. 2017-04 in 2019 did not have
a material impact on our consolidated financial position, results of operations,
and cash flows.

In February 2016, the FASB issued ASU No. 2016-02, "Leases (Topic 842)." ASU No.
2016-02 requires that lessees recognize virtually all of their leases on the
balance sheet, by recording a right-of-use asset and lease liability. On January
1, 2019, we adopted ASU No. 2016-02 using the modified retrospective method
which applies the provisions of the standard at the effective date without
adjusting the comparative periods presented. We also elected the package of
practical expedients.

There was not a cumulative-effect adjustment to our beginning retained earnings
as a result of adopting ASU No. 2016-02. We recognized additional operating
lease assets and obligations of $14.4 million as of January 1, 2019. As a result
of the Merger, operating lease assets and obligations of $9.7 million were
assumed from the former Nanometrics. We elected to not reassess prior
conclusions related to the identification, classification and accounting for
initial direct costs for leases that commenced prior to January 1, 2019. For
additional disclosure and detail, see Note 7 of the Notes to the Consolidated
Financial Statements included in this Annual Report on Form 10-K.

Recently Issued



In December 2019, the FASB issued ASU No. 2019-12, "Income Taxes (Topic 740):
Simplifying the Accounting for Income Taxes." This standard simplifies the
accounting for income taxes by eliminating certain exceptions to the guidance in
Topic 740 related to the approach for intraperiod tax allocation, the
methodology for calculating income taxes in an interim period and the
recognition of deferred tax liabilities for outside basis differences. The new
guidance also simplifies aspects of the accounting for franchise taxes and
enacted changes in tax laws or rates and clarifies the accounting for
transactions that result in a step-up in the tax basis of goodwill and
allocating consolidated income taxes to separate financial statements of
entities not subject to income tax. ASU No. 2019-12 is effective for fiscal
years beginning after December 15, 2020, with early adoption permitted. Upon
adoption, we must apply certain aspects of this standard retrospectively for all
periods presented while other aspects are applied on a modified retrospective
basis through a cumulative-effect adjustment to retained earnings as of the
beginning of the fiscal year of adoption. We are currently evaluating the impact
of this new standard on our consolidated financial position, results of
operations, and cash flows.

In August 2018, the FASB issued ASU No. 2018-13, "Fair Value Measurement (Topic
820): Disclosure Framework - Changes to the Disclosure Requirements for Fair
Value Measurement." This ASU is part of the FASB's larger disclosure framework
project intended to improve the effectiveness of financial statement footnote
disclosure. ASU No. 2018-13 modifies required fair value disclosures related
primarily to level 3 investments. This ASU is effective for annual periods
beginning after December 15, 2019 and interim periods within those annual
periods. The adoption of ASU No. 2018-13 is not expected to have a material
effect on our consolidated financial position, results of operations, and cash
flows.

In May 2017, the FASB issued ASU No. 2017-09, "Compensation - Stock Compensation
(Topic 718): Scope of Modification Accounting." This ASU amends the scope of
modification accounting for share-based payment arrangements and provides
guidance on the types of changes to the terms or conditions of share-based
payment awards to which an entity would be required to apply modification
accounting under ASC 718. The ASU is effective for the fiscal years beginning
after December 15, 2019 and for interim periods within those fiscal years. The
adoption of ASU No. 2017-09 is not expected to have a material effect on our
consolidated financial position, results of operations, and cash flows, if any.

In June 2016, the FASB issued ASU No. 2016-13, "Financial Instruments - Credit
Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,"
which represents a new credit loss standard that will change the impairment
model for most financial assets and certain other financial instruments.
Specifically, this guidance will require entities to utilize a new "expected
loss" model as it relates to trade receivables, notes receivable and other
commitments to extend credit held by a reporting entity. In addition, entities
will be required to recognize an allowance for estimated credit losses on



                                       37

--------------------------------------------------------------------------------

Table of Contents





available-for-sale debt securities, regardless of the length of time that a
security has been in an unrealized loss position. This guidance will be
effective for annual reporting periods beginning after December 15, 2019,
including interim periods within those annual reporting periods, with early
adoption permitted. We expect that the adoption of this guidance will not have a
material impact on our consolidated financial position, results of operations,
and cash flows.

Recently issued accounting guidance not discussed above is not applicable or did not have, or is not expected to have, a material impact to the Company.

© Edgar Online, source Glimpses